Area riservata



 




Chirurgia del tunnel carpale

Commenti agli articoli

Specialistica
EACAAI, Excellence In Clinical Education, Communication And Patient Care
AllergologiaBe among the first to hear the latest research from the world's leading allergists presented at the 2010 annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI), Nov. 11-16, in Phoenix... ... ...
 
DNA From National Psoriasis Victor Henschel BioBank Released For Study
AllergologiaMillions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the first-ever release of National Psoriasis Victor Henschel BioBank DNA samples for use in psoriasis research. The samples will allow scientis ... ...
 
GreenVax Selects Xcellerex XDR Single-Use Bioreactors For New Vaccine And Biotherapeutics Program
AllergologiaXcellerex, Inc. announced that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility currently under construction in Bryan, Texas. Project GreenVax is spearhead ... ...
 
Why Females Fare Better Than Males After Traumatic Injury
AllergologiaA study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estro ... ...
 
Shionogi Announces Positive Outcome To The Decentralized Procedure For The European Approval Of Twinject(R) (Epinephrine Auto-Injector)
AllergologiaShionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd... ... ...
 
Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health data
CardiologiaBackground:Peripheral arterial disease (PAD) is caused by narrowing of the arteries in the lower extremities. Limited data exist concerning the impact of diffuse vascular disease (DVD) on prognosis and costs. Thus, the objective of this study is to ... ...
 
BRINAVESS (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation
CardiologiaMerck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp... ... ...
 
<< Inizio < Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >>

Pagina 1 di 2481